These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1335646)

  • 1. Simultaneous passive and active immunization against hepatitis A.
    Leentvaar-Kuijpers A; Coutinho RA; Brulein V; Safary A
    Vaccine; 1992; 10 Suppl 1():S138-41. PubMed ID: 1335646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers.
    Wagner G; Lavanchy D; Darioli R; Pécoud A; Brulein V; Safary A; Frei PC
    Vaccine; 1993; 11(10):1027-32. PubMed ID: 8212822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
    Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of vaccine-induced antibody to hepatitis A virus.
    Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE
    Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A vaccination: schedule for accelerated immunization.
    Müller R; Chriske H; Deinhardt F; Jilg J; Theilmann L; Hess G; Hofmann F; Hopf U; Stickl H; Maiwald H
    Vaccine; 1992; 10 Suppl 1():S124-5. PubMed ID: 1335641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of inactivated hepatitis A vaccine in children.
    Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A
    Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous vaccination against hepatitis A and B: results of a controlled study.
    Ambrosch F; André FE; Delem A; D'Hondt E; Jonas S; Kunz C; Safary A; Wiedermann G
    Vaccine; 1992; 10 Suppl 1():S142-5. PubMed ID: 1335647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field evaluation of a hepatitis A vaccine in a Norwegian contingent to the United Nations Interim Force in Lebanon.
    Aarhaug P
    Vaccine; 1992; 10 Suppl 1():S156-8. PubMed ID: 1335651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivated hepatitis A vaccine in childhood: implications for disease control.
    Nalin D; Brown L; Kuter B; Patterson C; McGuire B; Werzberger A; Santosham M; Block S; Reisinger K; Watson B
    Vaccine; 1993; 11 Suppl 1():S15-7. PubMed ID: 8383388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of hepatitis A vaccine in healthy children.
    Horng YC; Chang MH; Lee CY; Safary A; Andre FE; Chen DS
    Pediatr Infect Dis J; 1993 May; 12(5):359-62. PubMed ID: 8392163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
    Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.